FDA Adverse Event Injury Summary report: N

IMPLANTABLE INFUSION PUMP

MDR report key: 6800448 · Received August 17, 2017

Report

Report Number
3007566237-2017-03333
Event Type
Injury
Date Received
August 17, 2017
Date of Event
September 10, 2003
Report Date
August 17, 2017
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
LKK
PMA / PMN Number
P860004
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

IT WAS NOT POSSIBLE TO MATCH THIS EVENT WITH ANY PREVIOUSLY REPORTED EVENT. INFORMATION REFERENCES THE MAIN COMPONENT OF THE SYSTEM AND OTHER APPLICABLE COMPONENTS ARE: PRODUCT ID: NEU_UNKNOWN_CATH, LOT# SERIAL# UNKNOWN, PRODUCT TYPE: CATHETER. A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

STAAL, C., ARENDS, A., HO, S. A SELF-REPORT OF QUALITY OF LIFE OF PATIENTS RECEIVING INTRATHECAL BACLOFEN THERAPY. REHABILITATION NURSING. 2003. 28(5):159-63. DOI: 10.1002/J.2048-7940.2003.TB02050. SUMMARY: THE PURPOSE OF THIS STUDY WAS TO EXPLORE THROUGH A DEPARTMENT QUALITY IMPROVEMENT TOOL A POSSIBLE RELATION BETWEEN QUALITY OF LIFE (QOL), COMPLICATION RATES, AND LENGTH OF INTRATHECAL BACLOFEN (IB) TREATMENT AS REPORTED BY PATIENTS RECEIVING IB THERAPY IN A COMMUNITY BASED REHABILITATION CENTER OUTPATIENT CLINIC. REPORTED EVENTS: THE MOST COMMON COMPLICATIONS CITED WERE INFECTION AND CATHETER BREAKAGE OR DISCONNECT. THE OVERALL INFECTION RATE FOR RESPONDENTS WAS 10% (5 PATIENTS OF THE 49 SURVEYED REPORTED INFECTION). THE MOST COMMON COMPLICATIONS CITED WERE INFECTION AND CATHETER BREAKAGE OR DISCONNECT. THE RATE OF CATHETER BREAKAGE OR DISCONNECT WAS 10%.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
582053 IMPLANTABLE INFUSION PUMP PUMP, INFUSION, IMPLANTED, PROGRAMMABLE LKK MEDTRONIC NEUROMODULATION NEU_UNKNOWN_PUMP

Patients

Seq Age Sex Outcome Treatment
1 Other